Clinical Trial Update: The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness [NA]

View source ↗

Summary

Completed clinical trial update on the Paradigm II trial evaluating the PFX Closure System for closing patent foramen ovale to reduce risk of cryptogenic stroke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompression Sickness
• Migraine
• Patent Foramen Ovale
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• PFX Closure System

Snippet

Sponsor: Cierra | Conditions: Foramen Ovale, Patent | NA | Status: COMPLETED